Turkish Cognitive Self-Efficacy Questionnaire in Parkinson's Disease
ConditionParkinson Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-85
SponsorAcibadem University
This study aims to evaluate the validity and reliability of the Turkish version of the Cognitive Self-Efficacy Questionnaire in individuals with Parkinson's disease.
Clinical diagnosis of Parkinson's disease
Hoehn and Yahr stage 1-3
Age 40 to 85 years
Mini-Mental State Examination (MMSE) score ≥24
Major depressive disorder or psychotic disorder
Advanced dementia
Severe visual impairment that may interfere with study assessments
Severe hearing impairment that may interfere with study assessments